457 related articles for article (PubMed ID: 31032942)
1. Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway.
Huang Y; Wan T; Pang N; Zhou Y; Jiang X; Li B; Gu Y; Huang Y; Ye X; Lian H; Zhang Z; Yang L
J Cell Physiol; 2019 Nov; 234(11):21224-21234. PubMed ID: 31032942
[TBL] [Abstract][Full Text] [Related]
2. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
Sui YH; Luo WJ; Xu QY; Hua J
World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
[TBL] [Abstract][Full Text] [Related]
3. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling.
Yuan C; Liu C; Wang T; He Y; Zhou Z; Dun Y; Zhao H; Ren D; Wang J; Zhang C; Yuan D
Oncotarget; 2017 May; 8(19):31023-31040. PubMed ID: 28415686
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
5. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit.
Flores-Costa R; Duran-Güell M; Casulleras M; López-Vicario C; Alcaraz-Quiles J; Diaz A; Lozano JJ; Titos E; Hall K; Sarno R; Masferrer JL; Clària J
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28263-28274. PubMed ID: 33106416
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O
Cells; 2022 Apr; 11(9):. PubMed ID: 35563697
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
Kong F; Ye B; Lin L; Cai X; Huang W; Huang Z
Biomed Pharmacother; 2016 Aug; 82():167-72. PubMed ID: 27470352
[TBL] [Abstract][Full Text] [Related]
10. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
12. GEN-27 exhibits anti-inflammatory effects by suppressing the activation of NLRP3 inflammasome and NF-κB pathway.
Hu M; Li X; Zhang J; Yuan Z; Fu Y; Ma X; Ren N
Cell Biol Int; 2019 Oct; 43(10):1184-1192. PubMed ID: 30632647
[TBL] [Abstract][Full Text] [Related]
13. Sinigrin inhibits production of inflammatory mediators by suppressing NF-κB/MAPK pathways or NLRP3 inflammasome activation in macrophages.
Lee HW; Lee CG; Rhee DK; Um SH; Pyo S
Int Immunopharmacol; 2017 Apr; 45():163-173. PubMed ID: 28219839
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway.
Jiang Y; Du H; Liu X; Fu X; Li X; Cao Q
J Drug Target; 2020 Jan; 28(1):70-79. PubMed ID: 31094238
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS
Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629
[TBL] [Abstract][Full Text] [Related]
16. Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model.
Vargas-Pozada EE; Ramos-Tovar E; Rodriguez-Callejas JD; Cardoso-Lezama I; Galindo-Gómez S; Talamás-Lara D; Vásquez-Garzón VR; Arellanes-Robledo J; Tsutsumi V; Villa-Treviño S; Muriel P
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077357
[TBL] [Abstract][Full Text] [Related]
17. Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity.
Hoque R; Farooq A; Ghani A; Gorelick F; Mehal WZ
Gastroenterology; 2014 Jun; 146(7):1763-74. PubMed ID: 24657625
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
19. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway.
Liu Q; Zuo R; Wang K; Nong FF; Fu YJ; Huang SW; Pan ZF; Zhang Y; Luo X; Deng XL; Zhang XX; Zhou L; Chen Y
Acta Pharmacol Sin; 2020 Jun; 41(6):771-781. PubMed ID: 31937929
[TBL] [Abstract][Full Text] [Related]
20. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder.
Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
Eur J Pharmacol; 2017 Aug; 809():141-150. PubMed ID: 28526339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
